Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3588)
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
1,175
Price
$93.95
Total Value
$110.39K
Shares Held After
46,355
% of Holdings
2.5%
Mirum Pharmaceuticals, Inc. (MIRM)
BJERKHOLT ERIC — CHIEF FINANCIAL OFFICER
Shares
2,258
Price
$92.84
Total Value
$209.63K
Shares Held After
47,530
% of Holdings
4.5%
ABEONA THERAPEUTICS INC. (ABEO)
Seshadri Vishwas — Director
Shares
24,428
Price
$5.43
Total Value
$132.63K
Shares Held After
1,405,995
% of Holdings
1.7%
ABEONA THERAPEUTICS INC. (ABEO)
Vasanthavada Madhav — Chief Commercial Officer
Shares
4,170
Price
$5.43
Total Value
$22.64K
Shares Held After
308,901
% of Holdings
1.3%
ABEONA THERAPEUTICS INC. (ABEO)
Vazzano Joseph Walter — Chief Financial Officer
Shares
10,271
Price
$5.43
Total Value
$55.77K
Shares Held After
557,504
% of Holdings
1.8%
ABEONA THERAPEUTICS INC. (ABEO)
O'Malley Brendan M. — SVP, Chief Legal Officer
Shares
4,826
Price
$5.43
Total Value
$26.20K
Shares Held After
446,308
% of Holdings
1.1%
FRACTYL HEALTH, INC. (GUTS)
Smith Weber Lara — Chief Financial Officer
Shares
20,000
Price
$0.69
Total Value
$13.71K
Shares Held After
20,000
% of Holdings
100.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
80
Price
$551.75
Total Value
$44.14K
Shares Held After
18,876
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
610
Price
$551.28
Total Value
$336.28K
Shares Held After
18,956
% of Holdings
3.1%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,285
Price
$550.09
Total Value
$706.87K
Shares Held After
19,566
% of Holdings
6.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
425
Price
$549.38
Total Value
$233.49K
Shares Held After
20,851
% of Holdings
2.0%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
2,158
Price
$547.91
Total Value
$1.18M
Shares Held After
21,276
% of Holdings
9.2%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,888
Price
$547.03
Total Value
$1.03M
Shares Held After
23,434
% of Holdings
7.5%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,989
Price
$546.13
Total Value
$1.09M
Shares Held After
25,322
% of Holdings
7.3%
UNITED THERAPEUTICS Corp (UTHR)
EDGEMOND JAMES — CFO AND TREASURER
Shares
1,565
Price
$544.93
Total Value
$852.82K
Shares Held After
27,311
% of Holdings
5.4%
Tonix Pharmaceuticals Holding Corp. (TNXP)
Stillwell Richard Newcomb — Director
Shares
5,000
Price
$11.65
Total Value
$58.25K
Shares Held After
5,000
% of Holdings
100.0%
Dyne Therapeutics, Inc. (DYN)
Posner Brian S — Director
Shares
2,000
Price
$16.94
Total Value
$33.88K
Shares Held After
24,500
% of Holdings
8.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$551.37
Total Value
$352.88K
Shares Held After
40,513
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
650
Price
$550.40
Total Value
$357.76K
Shares Held After
41,153
% of Holdings
1.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
948
Price
$549.58
Total Value
$521.01K
Shares Held After
41,803
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,144
Price
$547.93
Total Value
$1.17M
Shares Held After
42,751
% of Holdings
4.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,525
Price
$547.07
Total Value
$834.28K
Shares Held After
44,895
% of Holdings
3.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,131
Price
$546.13
Total Value
$1.16M
Shares Held After
46,420
% of Holdings
4.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,462
Price
$544.89
Total Value
$796.63K
Shares Held After
48,551
% of Holdings
2.9%
Century Therapeutics, Inc. (IPSC)
Russotti Gregory — Chief Technology and Manufacturing Officer
Shares
524
Price
$2.11
Total Value
$1.11K
Shares Held After
514,903
% of Holdings
0.1%
Century Therapeutics, Inc. (IPSC)
Carr Douglas — SVP Finance & Operations
Shares
249
Price
$2.11
Total Value
$525.64
Shares Held After
506,748
% of Holdings
0.0%
UroGen Pharma Ltd. (URGN)
Schoenberg Mark — Chief Medical Officer
Shares
5,222
Price
$27.30
Total Value
$142.56K
Shares Held After
139,763
% of Holdings
3.6%
Werewolf Therapeutics, Inc. (HOWL)
EVNIN LUKE — Director
Shares
60,547
Price
$0.40
Total Value
$24.22K
Shares Held After
377,211
% of Holdings
13.8%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
5,045
Price
$1.57
Total Value
$7.92K
Shares Held After
69,553
% of Holdings
7.3%
InMed Pharmaceuticals Inc. (INM)
Vivo Opportunity, LLC — 10% Owner
Shares
49,966
Price
$1.57
Total Value
$78.45K
Shares Held After
688,926
% of Holdings
7.3%
Metagenomi Therapeutics, Inc. (MGX)
Wapnick Pamela — Chief Financial Officer
Shares
2,884
Price
$1.30
Total Value
$3.75K
Shares Held After
208,491
% of Holdings
1.4%
Metagenomi Therapeutics, Inc. (MGX)
Wein Matthew — General Counsel, Compliance Officer and Corporate Secretary
Shares
558
Price
$1.30
Total Value
$724.84
Shares Held After
126,491
% of Holdings
0.4%
Metagenomi Therapeutics, Inc. (MGX)
Irish Jian — Director
Shares
3,737
Price
$1.30
Total Value
$4.85K
Shares Held After
377,533
% of Holdings
1.0%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
1,000
Price
$19.27
Total Value
$19.27K
Shares Held After
43,415
% of Holdings
2.3%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
3,500
Price
$19.46
Total Value
$68.11K
Shares Held After
42,415
% of Holdings
8.3%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
6,000
Price
$19.48
Total Value
$116.88K
Shares Held After
38,915
% of Holdings
15.4%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
10,000
Price
$19.41
Total Value
$194.10K
Shares Held After
32,915
% of Holdings
23.3%
Immunome Inc. (IMNM)
BIENAIME JEAN JACQUES — Director
Shares
500
Price
$19.44
Total Value
$9.72K
Shares Held After
42,915
% of Holdings
1.2%
Enliven Therapeutics, Inc. (ELVN)
Kunkel Lori Anne — Director
Shares
354
Price
$35.82
Total Value
$12.68K
Shares Held After
51,884
% of Holdings
0.7%
Enliven Therapeutics, Inc. (ELVN)
Kunkel Lori Anne — Director
Shares
1,867
Price
$35.36
Total Value
$66.01K
Shares Held After
52,238
% of Holdings
3.5%
Enliven Therapeutics, Inc. (ELVN)
Kunkel Lori Anne — Director
Shares
7,779
Price
$34.28
Total Value
$266.66K
Shares Held After
54,105
% of Holdings
12.6%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
1,745
Price
$450.00
Total Value
$785.25K
Shares Held After
21,015
% of Holdings
7.7%
Ainos, Inc. (AIMD)
chiang yao-chung — Director
Shares
3,500
Price
$2.05
Total Value
$7.17K
Shares Held After
11,279
% of Holdings
31.0%
Xenon Pharmaceuticals Inc. (XENE)
Cannon Gillian — Director
Shares
1,190
Price
$53.14
Total Value
$63.24K
Shares Held After
1,455
% of Holdings
45.0%
Xenon Pharmaceuticals Inc. (XENE)
PATOU GARY — Director
Shares
1,322
Price
$53.14
Total Value
$70.25K
Shares Held After
24,896
% of Holdings
5.0%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
4,415
Price
$68.96
Total Value
$304.46K
Shares Held After
4,318,447
% of Holdings
0.1%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
8,437
Price
$67.88
Total Value
$572.74K
Shares Held After
4,322,862
% of Holdings
0.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
7,148
Price
$67.20
Total Value
$480.34K
Shares Held After
4,331,299
% of Holdings
0.2%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
4,416
Price
$68.96
Total Value
$304.52K
Shares Held After
515,686
% of Holdings
0.8%
BridgeBio Pharma, Inc. (BBIO)
Kumar Neil — Director
Shares
8,437
Price
$67.88
Total Value
$572.74K
Shares Held After
520,102
% of Holdings
1.6%
Showing 451–500 of 3588 transactions (page 10 of 72)